PE Tech Report


Like this article?

Sign up to our free newsletter

British Patient Capital Commits EUR25m to Nauta Capital’s fifth fund

British Patient Capital has made a EUR25 million commitment to the Nauta Tech Invest V Fund, as Nauta Capital announces its final close at EUR190 million. 

Investing from late seed and Series A, the fund has already invested in 11 companies in verticals including Fintech, Insurtech, Retailtech, and Open Source, among others.
Nauta Capital specialises in capital-efficient early-stage B2B software companies. The firm’s main areas of interest include SaaS solutions with strong network effects, vertically focused enterprise tech with the potential to transform large industries as well as those leveraging deeptech applications to solve challenges faced by large enterprises.
This investment by British Patient Capital to Nauta’s fifth fund follows its previous commitments to Nauta’s fourth fund, and its ‘Sidecar’ fund dedicated to backing Nauta’s existing later-stage portfolio companies.
Judith Hartley, CEO, British Patient Capital, says: “We are excited to extend our relationship with Nauta through our anchor investment to their fifth fund. Businesses today are constantly challenged to enhance processes, increase productivity and improve employee wellbeing. This creates a significant opportunity for innovative B2B software companies, and the potential for compelling returns for their investors. Nauta is well placed to identify, back, and then support the growth of these types of high-growth companies.
Carles Ferrer, General Partner, Nauta, says: “At EUR190 million this is our biggest fund to date, and one of Europe’s largest B2B funds, giving us the ability to follow on at later stages. British Patient Capital has been instrumental in this fundraising, and we are grateful for their continued trust in us and our investment strategy.”

Like this article? Sign up to our free newsletter